The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy

被引:3
作者
Berwald, Grace [1 ]
Young, Graeme P. [2 ]
Cock, Charles [3 ]
Bampton, Peter [2 ]
Fraser, Robert [3 ]
Symonds, Erin L. [3 ,4 ]
机构
[1] Flinders Univ S Australia, Coll Med & Publ Hlth, Dept Med, Bedford Pk, SA, Australia
[2] Flinders Hlth & Med Res Inst, Canc Res, Bedford Pk, SA, Australia
[3] Southern Adelaide Local Hlth Network, Flinders Med Ctr, Dept Gastroenterol & Hepatol, Bedford Pk, SA, Australia
[4] Flinders Ctr Innovat Canc, Level 3,Flinders Dr, Bedford Pk, SA 5042, Australia
关键词
Fecal Immunochemical Test; Colonoscopy; Surveillance; Colorectal Neoplasia; COLORECTAL-CANCER; HYPERPLASTIC POLYPS; SERRATED ADENOMAS; RISK-FACTORS;
D O I
10.1016/j.cgh.2023.09.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: An increasing burden on health care resources has resulted in a backlog of individuals requiring colonoscopy, with delays in surveillance possibly detrimental for individuals at increased risk of colorectal cancer (CRC). This study investigated the use of a 2 -sample fecal immunochemical test (FIT) to establish those most likely to have advanced neoplasia (AN) and in need of prioritized surveillance colonoscopy. METHODS: This was a prospective study conducted in the tertiary care setting. Participants completed a 2sample FIT (OC-Sensor, Eiken Chemical Company) within 90 days of surveillance colonoscopy. The sensitivity of FIT for detection of AN (CRC or advanced adenoma) in moderate- and highrisk individuals was determined at fecal hemoglobin thresholds between 2 and 80 mu g/g feces. RESULTS: A total of 766 patients were included (median age, 66.1 years [interquartile range, 58.1 - 72.9]; 49.9% male), with AN detected in 8.6% (66/766, including 5 CRC). For moderate -risk individuals (with prior history of adenoma or a signi fi cant family history of CRC), sensitivity of FIT for AN ranged from 73.5% at 2 mu g/g feces, to 10.2% at 80 mu g/g feces. For high -risk conditions (con fi rmed/suspected genetic syndromes or prior CRC), sensitivity of FIT was similar, ranging from 70.6% at the lowest positivity threshold of 2 mu g/g feces, to 11.8% at 80 mu g/g feces. Independent variables in the whole cohort for association with detection of AN at surveillance colonoscopy were age (odds ratio, 1.03; 95% con fi dence interval, 1.00 - 1.06) and FIT hemoglobin result double dagger 10 mu g/g feces (odds ratio, 1.81; 95% con fi dence interval, 1.04 - 3.16). CONCLUSIONS: The use of FIT before surveillance colonoscopy provides clinicians with insights into the risk of AN. This raises the possibility of a method to triage individuals, facilitating the more ef fi cient management of endoscopic resources.
引用
收藏
页码:878 / 885.e2
页数:10
相关论文
共 28 条
  • [11] Sporadic and syndromic hyperplastic polyps & serrated adenomas of the colon: Classification, molecular genetics, natural history, and clinical management
    East, James E.
    Saunders, Brian P.
    Jass, Jeremy R.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2008, 37 (01) : 25 - +
  • [12] Edge S, 2017, AJCC cancer staging manual
  • [13] RISK-FACTORS FOR BLOOD-LOSS FROM ADENOMATOUS POLYPS OF THE LARGE BOWEL - A COLONOSCOPIC EVALUATION WITH HISTOPATHOLOGICAL CORRELATION
    FOUTCH, PG
    MANNE, RK
    SANOWSKI, RA
    GAINES, JA
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (01) : 50 - 56
  • [14] Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy
    Gupta, Samir
    Earles, Ashley
    Bustamante, Ranier
    V. Patterson, Olga
    Gawron, Andrew J.
    Kaltenbach, Tonya R.
    Yassin, Hanin
    Lamm, Mark
    Shah, Shailja C.
    Saini, Sameer Dev
    Fisher, Deborah A.
    Martinez, Maria Elena
    Messer, Karen
    Demb, Joshua
    Liu, Lin
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1924 - 1936
  • [15] Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross- sectional nationwide assessment
    Han, Xuesong
    Yang, Nuo Nova
    Nogueira, Leticia
    Jiang, Changchuan
    Wagle, Nikita Sandeep
    Zhao, Jingxuan
    Shi, Kewei Sylvia
    Fan, Qinjin
    Schafer, Elizabeth
    Yabroff, K. Robin
    Jemal, Ahmedin
    [J]. LANCET ONCOLOGY, 2023, 24 (08) : 855 - 867
  • [16] Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and Death
    Kaminski, Michal F.
    Wieszczy, Paulina
    Rupinski, Maciej
    Wojciechowska, Urszula
    Didkowska, Joanna
    Kraszewska, Ewa
    Kobiela, Jaroslaw
    Franczyk, Robert
    Rupinska, Maria
    Kocot, Bartlomiej
    Chaber-Ciopinska, Anna
    Pachlewski, Jacek
    Polkowski, Marcin
    Regula, Jaroslaw
    [J]. GASTROENTEROLOGY, 2017, 153 (01) : 98 - 105
  • [17] Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer A Meta-analysis
    Katsoula, Anastasia
    Paschos, Paschalis
    Haidich, Anna-Bettina
    Tsapas, Apostolos
    Giouleme, Olga
    [J]. JAMA INTERNAL MEDICINE, 2017, 177 (08) : 1110 - 1118
  • [18] Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals
    Lieberman, DA
    Prindiville, S
    Weiss, DG
    Willett, W
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (22): : 2959 - 2967
  • [19] Colonoscopy utilization and outcomes 2000 to 2011
    Lieberman, David A.
    Williams, J. Lucas
    Holub, Jennifer L.
    Morris, Cynthia D.
    Logan, Judith R.
    Eisen, Glenn M.
    Carney, Patricia
    [J]. GASTROINTESTINAL ENDOSCOPY, 2014, 80 (01) : 133 - U353
  • [20] Colorectal cancer population screening programs worldwide in 2016: An update
    Navarro, Mercedes
    Nicolas, Andrea
    Ferrandez, Angel
    Lanas, Angel
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (20) : 3632 - 3642